• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-肾上腺素能受体配体通过干扰异源三聚体形成来抑制α-肾上腺素能受体的趋化因子受体异源三聚体伙伴。

α-adrenoceptor ligands inhibit chemokine receptor heteromerization partners of α-adrenoceptors via interference with heteromer formation.

机构信息

Department of Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.

Department of Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL, USA; Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.

出版信息

Pharmacol Res. 2023 Apr;190:106730. doi: 10.1016/j.phrs.2023.106730. Epub 2023 Mar 15.

DOI:10.1016/j.phrs.2023.106730
PMID:36925091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10108735/
Abstract

We reported previously that α-adrenoceptor (α-AR) ligands inhibit chemokine receptor (CR) heteromerization partners of α-AR. The underlying mechanisms are unknown and in vivo evidence for such effects is missing. Utilizing CCR2 and α-AR as prototypical partners, we observed in recombinant systems and THP-1 cells that α-AR enhanced whereas its absence inhibited Gαi signaling of CCR2. Phenylephrine and phentolamine reduced the CCR2:α-AR heteromerization propensity and inhibited Gαi signaling of CCR2. Phenylephrine cross-recruited β-arrestin-2 to CCR2, and reduced expression of α-AR, CR partners (CCR1/2, CXCR4) and corresponding heteromers. Phentolamine reduced CR:α-AR heteromers without affecting β-arrestin-2 recruitment or receptor expression. Phenylephrine/phentolamine prevented leukocyte infiltration mediated via CR heteromerization partners in a murine air pouch model. Our findings document that α-AR ligands inhibit leukocyte migration mediated by CR heteromerization partners in vivo and suggest interference with α-AR:CR heteromerization as a mechanism by which CR partners are inhibited. These findings provide new insights into the pharmacology of GPCR heteromers and indicate that an agonist and antagonist at one GPCR can act as antagonists at heteromerization partners of their target receptors.

摘要

我们之前曾报道过,α-肾上腺素受体 (α-AR) 配体抑制趋化因子受体 (CR) 作为 α-AR 的异源三聚体伙伴。其潜在机制尚不清楚,也缺乏体内相关证据。利用 CCR2 和 α-AR 作为典型的伙伴,我们在重组系统和 THP-1 细胞中观察到,α-AR 增强了 CCR2 的 Gαi 信号,而其缺失则抑制了 CCR2 的 Gαi 信号。苯肾上腺素和酚妥拉明降低了 CCR2:α-AR 异源三聚体形成的倾向,并抑制了 CCR2 的 Gαi 信号。苯肾上腺素将β-arrestin-2 募集到 CCR2 上,并降低了 α-AR、CR 伙伴(CCR1/2、CXCR4)和相应异源三聚体的表达。酚妥拉明降低了 CR:α-AR 异源三聚体,而不影响β-arrestin-2 的募集或受体表达。苯肾上腺素/酚妥拉明在小鼠气囊模型中预防了通过 CR 异源三聚体伙伴介导的白细胞浸润。我们的研究结果证明了 α-AR 配体在体内抑制了由 CR 异源三聚体伙伴介导的白细胞迁移,并提示干扰 α-AR:CR 异源三聚体形成可能是抑制 CR 伙伴的一种机制。这些发现为 GPCR 异源三聚体的药理学提供了新的见解,并表明一个 GPCR 的激动剂和拮抗剂可以作为其靶受体的异源三聚体伙伴的拮抗剂。

相似文献

1
α-adrenoceptor ligands inhibit chemokine receptor heteromerization partners of α-adrenoceptors via interference with heteromer formation.α-肾上腺素能受体配体通过干扰异源三聚体形成来抑制α-肾上腺素能受体的趋化因子受体异源三聚体伙伴。
Pharmacol Res. 2023 Apr;190:106730. doi: 10.1016/j.phrs.2023.106730. Epub 2023 Mar 15.
2
α-Adrenergic Receptors Function Within Hetero-Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C-X-C motif) Receptor 4 in Vascular Smooth Muscle Cells.α-肾上腺素能受体在血管平滑肌细胞中与非典型趋化因子受体 3 和趋化因子(C-X-C 基序)受体 4 形成异源寡聚复合物中发挥作用。
J Am Heart Assoc. 2017 Aug 17;6(8):e006575. doi: 10.1161/JAHA.117.006575.
3
Heteromerization between α -adrenoceptor and chemokine (C-C motif) receptor 2 biases α -adrenoceptor signaling: Implications for vascular function.α-肾上腺素能受体与趋化因子(C-C 基序)受体 2 之间的异源二聚化偏向 α-肾上腺素能受体信号传导:对血管功能的影响。
FEBS Lett. 2022 Oct;596(20):2706-2716. doi: 10.1002/1873-3468.14463. Epub 2022 Aug 9.
4
G protein activation via chemokine (C-X-C motif) receptor 4 and α -adrenoceptor is ligand and heteromer-dependent.G 蛋白通过趋化因子(C-X-C 基序)受体 4 和 α-肾上腺素能受体的激活是配体和异源二聚体依赖性的。
FEBS Lett. 2023 Aug;597(15):2017-2027. doi: 10.1002/1873-3468.14692. Epub 2023 Jul 3.
5
Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α-adrenergic receptors at the heteromeric receptor complex.不对称配体诱导的α肾上腺素能受体对趋化因子(C-X-C 基序)受体 4 异源受体复合物的交叉调节。
Sci Rep. 2018 Feb 9;8(1):2730. doi: 10.1038/s41598-018-21096-4.
6
α-adrenoceptors regulate chemokine receptor-mediated leukocyte migration via formation of heteromeric receptor complexes.α-肾上腺素受体通过形成异源受体复合物调节趋化因子受体介导的白细胞迁移。
Proc Natl Acad Sci U S A. 2022 May 17;119(20):e2123511119. doi: 10.1073/pnas.2123511119. Epub 2022 May 10.
7
Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and α-adrenergic receptors utilizing intermolecular bioluminescence resonance energy transfer assays.利用分子间生物发光共振能量转移测定法鉴定趋化因子(C-X-C 基元)受体 4 与 α-肾上腺素能受体之间的异源二聚体复合物。
Biochem Biophys Res Commun. 2020 Jul 23;528(2):368-375. doi: 10.1016/j.bbrc.2020.02.094. Epub 2020 Feb 19.
8
New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle.趋化因子(C-X-C基序)受体4在血管平滑肌中异聚化的机制与功能新见解
Int J Mol Sci. 2016 Jun 20;17(5):971. doi: 10.3390/ijms17060971.
9
Chemokine receptor antagonists with α-adrenergic receptor blocker activity.具有α-肾上腺素能受体阻滞活性的趋化因子受体拮抗剂。
J Basic Clin Physiol Pharmacol. 2021 Jun 21;33(4):519-523. doi: 10.1515/jbcpp-2020-0523.
10
The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.三种α1-肾上腺素能受体亚型表现出不同的内化和ERK1/2磷酸化的时空机制。
Biochim Biophys Acta. 2013 Oct;1833(10):2322-33. doi: 10.1016/j.bbamcr.2013.06.013. Epub 2013 Jun 21.

引用本文的文献

1
β-Adrenoceptor Agonists Attenuate Thrombin-Induced Impairment of Human Lung Endothelial Cell Barrier Function and Protect the Lung Vascular Barrier during Resuscitation from Hemorrhagic Shock.β-肾上腺素能受体激动剂可减轻凝血酶诱导的人肺内皮细胞屏障功能损伤,并在失血性休克复苏过程中保护肺血管屏障。
Biomedicines. 2024 Aug 9;12(8):1813. doi: 10.3390/biomedicines12081813.
2
Chemokine receptor hetero-oligomers regulate monocyte chemotaxis.趋化因子受体异源寡聚体调节单核细胞趋化性。
Life Sci Alliance. 2024 May 23;7(8). doi: 10.26508/lsa.202402657. Print 2024 Aug.

本文引用的文献

1
GPCR heteromers: An overview of their classification, function and physiological relevance.G 蛋白偶联受体异源二聚体:分类、功能和生理相关性概述。
Front Endocrinol (Lausanne). 2022 Aug 30;13:931573. doi: 10.3389/fendo.2022.931573. eCollection 2022.
2
Heteromerization between α -adrenoceptor and chemokine (C-C motif) receptor 2 biases α -adrenoceptor signaling: Implications for vascular function.α-肾上腺素能受体与趋化因子(C-C 基序)受体 2 之间的异源二聚化偏向 α-肾上腺素能受体信号传导:对血管功能的影响。
FEBS Lett. 2022 Oct;596(20):2706-2716. doi: 10.1002/1873-3468.14463. Epub 2022 Aug 9.
3
α-adrenoceptors regulate chemokine receptor-mediated leukocyte migration via formation of heteromeric receptor complexes.
α-肾上腺素受体通过形成异源受体复合物调节趋化因子受体介导的白细胞迁移。
Proc Natl Acad Sci U S A. 2022 May 17;119(20):e2123511119. doi: 10.1073/pnas.2123511119. Epub 2022 May 10.
4
Plasticity of seven-transmembrane-helix receptor heteromers in human vascular smooth muscle cells.七跨膜螺旋受体同型聚体在人血管平滑肌细胞中的可塑性。
PLoS One. 2021 Jun 24;16(6):e0253821. doi: 10.1371/journal.pone.0253821. eCollection 2021.
5
Class A G protein-coupled receptors assemble into functional higher-order hetero-oligomers.A 类 G 蛋白偶联受体形成功能性的高级异源寡聚体。
FEBS Lett. 2021 Jul;595(14):1863-1875. doi: 10.1002/1873-3468.14135. Epub 2021 Jun 11.
6
UniProt: the universal protein knowledgebase in 2021.UniProt:2021 年的通用蛋白质知识库。
Nucleic Acids Res. 2021 Jan 8;49(D1):D480-D489. doi: 10.1093/nar/gkaa1100.
7
Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CC motif) receptor 4.化学趋化因子(CC 基序)受体 4 对凝血酶/蛋白酶激活受体 1 轴的调节作用。
J Biol Chem. 2020 Oct 30;295(44):14893-14905. doi: 10.1074/jbc.RA120.015355. Epub 2020 Aug 24.
8
TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome.TRUPATH,一个用于研究 G 蛋白偶联受体转导组学的开源生物传感器平台。
Nat Chem Biol. 2020 Aug;16(8):841-849. doi: 10.1038/s41589-020-0535-8. Epub 2020 May 4.
9
Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and α-adrenergic receptors utilizing intermolecular bioluminescence resonance energy transfer assays.利用分子间生物发光共振能量转移测定法鉴定趋化因子(C-X-C 基元)受体 4 与 α-肾上腺素能受体之间的异源二聚体复合物。
Biochem Biophys Res Commun. 2020 Jul 23;528(2):368-375. doi: 10.1016/j.bbrc.2020.02.094. Epub 2020 Feb 19.
10
Oligomerization of G protein-coupled receptors: Still doubted?G 蛋白偶联受体寡聚化:仍有争议?
Prog Mol Biol Transl Sci. 2020;169:297-321. doi: 10.1016/bs.pmbts.2019.11.006. Epub 2019 Dec 12.